GALECTIN-3 IN MODULATING INFLAMMATION IN ADIPOCYTES AND MACROPHAGES
Creators
- 1. Department of Biotechnology, Koneru Lakshmaiah Education Foundation, Guntur, Andhra Pradesh, India.
- 2. Department of Genetic Engineering, SRM institute of Science and Technology, Kattankulathur, Tamil Nadu, India.
- 3. Department of Biochemistry and Molecular Biology, Institute of Genetics and Hospital forGenetic Diseases, Osmania University, Begumpet,Hyderabad Telangana, India.
Description
Previous studies on endogenous galectin-3 proved its role in the pathogenesis of asthma, heart attack and obesity. Galectin-3 applied therapeutically as gene therapy suppresses the inflammatory response in a rat asthma model thus presenting novel therapeutic approach to the treatment of several diseases. Despite availability of enormous data concerning galectin-3 expression, the mechanisms of regulation of galectin-3 expression are relatively poorly defined. Galectins are either pro-inflammatory or anti-inflammatory, such as galectin-1, may be employed as anti-inflammatory agents, while others, such as galectin-3, are evidently suitable targets for anti-inflammatory drugs. Investigating galectin-3 in the immune response has demonstrated that this protein displays pro- and anti-inflammatory roles depending on the target cell type, whether galectin-3 is acting exogenously or endogenously, its expression level and other inflammatory factors. It is therefore imperative that all these factors be taken into consideration should galectin-3 be used therapeutically.
Files
81.pdf
Files
(778.7 kB)
Name | Size | Download all |
---|---|---|
md5:1e1122f38b987ff770ca277730a5ca0d
|
778.7 kB | Preview Download |